---
title: "Spondyloarthritis (SpA) Epidemiology and Key Presentation Features"
slug: "spondyloarthritis-spa-epidemiology-and-key-presentation-features"
date: "2023-08-05"
enableToc: false
tags:
  - building
---

> [!info]
>
> ðŸŒ± ä¾†è‡ª: [[seronegative spondyloarthritis]]

# Spondyloarthritis (SpA) Epidemiology and Key Presentation Features

| Disease                     | Epidemiology                                                                    |
| --------------------------- | ------------------------------------------------------------------------------- |
| Ankylosing spondylitis (AS) | â™‚:â™€ = 3:1; onset in teens to mid-20s (rare after 40 y)                          |
| Psoriatic arthritis (PsA)   | â™‚ = â™€; peak incidence 45-54 y; seen in 20-30% of Pts w/ psoriasis               |
| Reactive arthritis (ReA)    | â™‚ >> â™€; 20-40 y; 10-30 d after GI or GU infxn\* in genetically susceptible host |
| IBD-associated arthritis    | â™‚ = â™€; seen in 20% of IBD Pts; Crohnâ€™s >UC                                      |

---

| Disease                     | Key Features                                                                                                      |
| --------------------------- | ----------------------------------------------------------------------------------------------------------------- |
| Ankylosing spondylitis (AS) | Progressive limitation of spinal motion, a.m. stiffness, buttock pain, "bamboo spine," âŠ• Schober test             |
| Psoriatic arthritis (PsA)   | In 13-17% arthritis precedes skin findings by yrs; does not correlate with psoriasis activity; a/w HIV            |
| Reactive arthritis (ReA)    | Arthritis, urethritis, and conjunctivitis. Most resolve w/in 12 mo.                                               |
| IBD-associated arthritis    | Type I <5 joints: correlates w/ IBD activ. Type II >5 joints or axial disease: does not correlate w/ IBD activity |
